This weight loss stock is up 74% so far this year and is about to crash

Weight loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are conquering the pharmaceutical industry. While Eli Lilly And Novo Nordisk are major players in diabetes and obesity treatment thanks to their glucagon-like peptide-1 (GLP-1) agonists, but many companies are…